Bendamustine plus mitoxantrone for relapsed/refractory chronic lymphocytic leukaemia (CLL): results of a multicentre phase II study of the German CLL Study Group (GCLLSG).
about
Retreatment with bendamustine-containing regimens in patients with relapsed/refractory chronic lymphocytic leukemia and indolent B-cell lymphomas achieves high response rates and some long lasting remissions.Bendamustine and its role in the treatment of unfit patients with chronic lymphocytic leukaemia: a perspective review.'Use it again!': retherapy with bendamustine in indolent B-cell lymphoproliferative disorders.
P2860
Bendamustine plus mitoxantrone for relapsed/refractory chronic lymphocytic leukaemia (CLL): results of a multicentre phase II study of the German CLL Study Group (GCLLSG).
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Bendamustine plus mitoxantrone ...... rman CLL Study Group (GCLLSG).
@ast
Bendamustine plus mitoxantrone ...... rman CLL Study Group (GCLLSG).
@en
type
label
Bendamustine plus mitoxantrone ...... rman CLL Study Group (GCLLSG).
@ast
Bendamustine plus mitoxantrone ...... rman CLL Study Group (GCLLSG).
@en
prefLabel
Bendamustine plus mitoxantrone ...... rman CLL Study Group (GCLLSG).
@ast
Bendamustine plus mitoxantrone ...... rman CLL Study Group (GCLLSG).
@en
P2093
P2860
P921
P1476
Bendamustine plus mitoxantrone ...... rman CLL Study Group (GCLLSG).
@en
P2093
Christoph Losem
Daniel Reschke
Hans J Hurtz
Harald Fuss
Hubert Köppler
Johann Weiß
Owe Knigge
Rudolf Weide
Stephan Schmitz
P2860
P304
P356
10.1111/J.1365-2141.2012.09132.X
P407
P577
2012-05-10T00:00:00Z